# Temozolomide Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Malignant Glioma or Recurrent CNS or Other Solid Tumors

> **NCT00005952** · PHASE1,PHASE2 · COMPLETED · sponsor: **Duke University** · enrollment: 30 (estimated)

## Conditions studied

- Brain and Central Nervous System Tumors
- Childhood Germ Cell Tumor
- Head and Neck Cancer
- Kidney Cancer
- Neuroblastoma
- Ovarian Cancer
- Sarcoma
- Testicular Germ Cell Tumor

## Interventions

- **BIOLOGICAL:** filgrastim
- **DRUG:** temozolomide
- **PROCEDURE:** peripheral blood stem cell transplantation

## Key facts

- **NCT ID:** NCT00005952
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-08
- **Primary completion:** 2005-11
- **Final completion:** 2005-11
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2013-06-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00005952

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00005952, "Temozolomide Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Malignant Glioma or Recurrent CNS or Other Solid Tumors". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00005952. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*